Medical device maker Medtronic plc (NYSE: MDT) reported a modest increase in revenues and adjusted profit for the second quarter of 2025.
MDT Earnings: Highlights of Medtronic’s Q2 2025 financial results
Categories
Healthcare
Earnings Summary: Everything you need to know about Cardinal Health’s Q1 report
Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Friday reported an increase in adjusted profit for the first quarter of 2025,
Earnings Summary: HCA Healthcare reports Q3 2024 financial results
Hospital operator HCA Healthcare, Inc. (NYSE: HCA) on Friday announced financial and operating results for the third quarter ended September 30, 2024.
Earnings Summary: Everything you need to know about Centene’s Q3 report
Healthcare service provider Centene Corporation (NYSE: CNC) announced third-quarter 2024 results, reporting higher revenue and a decline in adjusted profit. Total revenues
Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year
ANGO Earnings: A snapshot of AngioDynamics’ Q1 2025 results
AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a net loss for the first quarter of 2025. The medical device company's revenues decreased by
Earnings Summary: A snapshot of DexCom’s Q2 2024 financial results
Healthcare company DexCom, Inc. (NASDAQ: DXCM) has reported an increase in revenue and adjusted earnings for the second quarter of 2024. The
Earnings Summary: Centene Corp’s Q2 2024 revenue and profit increase
Healthcare service provider Centene Corporation (NYSE: CNC) on Friday announced second-quarter 2024 results, reporting an increase in revenues and adjusted earnings. Total
Trxade Health closes business combination with Scienture in $103Mln deal
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, has announced the closing of its business combination with New York-based
UNH Earnings Preview: What to expect when UnitedHealth reports Q2 results
Health insurer UnitedHealth Group (NYSE: UNH) stands out in the healthcare space for its unique business model covering a broad range of
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a
Earnings Summary: Everything you need to know about Warby Parker’s Q1 results
Warby Parker Inc. (NYSE: WRBY), a leading eyewear retailer that sells prescription glasses and accessories, has reported higher revenues for the first
CVS Health Q1 adj. earnings drop despite revenue growth; guides FY24
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced first-quarter 2024 results, reporting higher revenues and a decrease in adjusted earnings. March-quarter adjusted
Archer-Daniels-Midland Company (ADM) reports lower Q4 revenue and earnings
Archer-Daniels-Midland Company (NYSE: ADM), a leading provider of human and animal nutrition solutions, on Tuesday reported earnings for the fourth quarter of
Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has enjoyed an
DHR Earnings: Danaher Corporation Q3 2023 sales and profit decline
Technology company Danaher Corporation (NYSE: DHR) Tuesday announced financial results for the third quarter of 2023, reporting lower sales and net profit. Third-quarter
General Electric Company (GE) Q3 2023 Earnings Call Transcript
General Electric Company (NYSE: GE) Q3 2023 Earnings Call dated Oct. 24, 2023 Corporate Participants: Steve Winoker -- Vice President, Investor Relations
JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call dated Oct. 17, 2023 Corporate Participants: Jessica Moore -- Vice President - Investor
Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024 when its
Cardinal Health Inc Q4 2023 Earnings Conference Call Insights
Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including its highest